Skip to main content
Log in

A monolysocardiolipin–cytochrome c peroxidase causes defects in Barth syndrome

  • Research Briefing
  • Published:

From Nature Metabolism

View current issue Submit your manuscript

We demonstrated increased phospholipid peroxidation due to the formation of monolysocardiolipin–cytochrome c complexes in tafazzin-deficient models of Barth syndrome. We found that a specific anti-peroxidase agent inhibited this complex and improved mitochondrial respiration. Thus, targeting the deleterious peroxidase activity offers a potential therapeutic approach to treat Barth syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1: Phospholipid oxidation and the effect of peroxidase inhibitors in BTHS models.

References

  1. Barth, P. G. et al. An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J. Neurol. Sci. 62, 327–355 (1983). This is the first report of the disorder now known as BTHS.

    Article  CAS  PubMed  Google Scholar 

  2. Vreken, P. et al. Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem. Biophys. Res. Commun. 279, 378–382 (2000). This paper identifies CL remodelling as the defect in BTHS.

    Article  CAS  PubMed  Google Scholar 

  3. Kagan, V. E. et al. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat. Chem. Biol. 1, 223–232 (2005). This paper shows formation of CL–cyt c complexes with peroxidase activity.

    Article  CAS  PubMed  Google Scholar 

  4. Claypool, S. M., McCaffery, J. M. & Koehler, C. M. Mitochondrial mislocalization and altered assembly of a cluster of Barth syndrome mutant tafazzins. J. Cell Biol. 174, 379–390 (2006). This paper shows that tafazzin is localized in the intermembrane space-facing leaflets of mitochondrial membranes.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Atkinson, J. et al. A mitochondria-targeted inhibitor of cytochrome c peroxidase mitigates radiation-induced death. Nat. Commun. 2, 497 (2011). This paper describes the design and synthesis of mitochondria-targeted imidazole-substituted fatty acids.

    Article  PubMed  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Kagan, V. E. et al. Anomalous peroxidase activity of cytochrome c is the primary pathogenic target in Barth syndrome. Nat. Metab. https://doi.org/10.1038/s42255-023-00926-4 (2023).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

A monolysocardiolipin–cytochrome c peroxidase causes defects in Barth syndrome. Nat Metab 5, 2043–2044 (2023). https://doi.org/10.1038/s42255-023-00925-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s42255-023-00925-5

  • Springer Nature Limited

Navigation